Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics hypoxia inducible factors'

Search results for: 'research area epigenetics hypoxia inducible factors'

Items 31-40 of 58

Page
per page
  1. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL
  2. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
  3. Trichostatin A (TSA)
    A8183 Trichostatin A (TSA)
     13 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; ≥15.12 mg/mL
  4. JNJ-26481585
    A4090 JNJ-26481585
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Potent HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
  5. UPF 1069
    A4163 UPF 1069
    Target: PARP
    Summary: Selective PARP2 inhibitor
      insoluble in H2O; ≥12.7 mg/mL
  6. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL
  7. CI994 (Tacedinaline)
    A4102 CI994 (Tacedinaline)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
  8. Fostriecin sodium salt
    A4536 Fostriecin sodium salt
    Target: PP1|PP2A|Topoisomerases|PP4
    Summary: Antitumor antibiotic
      Soluble in H2O
  9. I-CBP 112
    A4490 I-CBP 112
    Target: CREBBP|EP300
    Summary: CBP/EP300 bromodomain inhibitor
      ≥49.6 mg/mL
  10. NU 9056
    A4492 NU 9056
    Target: Histone Acetyltransferases (HATs)
    Summary: KAT5 (Tip60) HAT inhibitor
      <10 mg/mL

Items 31-40 of 58

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 3item
  2. Aurora Kinase 10item
  3. DNA Methyltransferase 4item
  4. HDAC 17item
  5. Histone Acetyltransferases 1 item
  6. Histone Demethylases 1 item
  7. Histone Methyltransferase 6item
  8. HIF 2item
  9. JAK 5item
  10. PARP 1 item
  11. Pim 2item
  12. Protein Ser/Thr Phosphatases 3item
  13. Sirtuin 4item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 17item
  3. Aurora Kinases 10item
  4. EZH2 2item
  5. Bromodomains 1 item
  6. FLT3 1 item
  7. Hydrolase 1 item
  8. MEK 1 item
  9. DOT1L 1 item
  10. Nrf2 1 item
  11. Pim 2item
  12. Sir2-like Family Deacetylases (Sirtuins) 3item
  13. PP1 1 item
  14. PP2A 1 item
  15. Src 1 item
  16. STAT 1 item
  17. Hypoxia Inducible Factors (HIFs) 1 item
  18. JAK 4item
  19. Topoisomerases 1 item
  20. DNA Methyltransferases 3item
  21. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  22. CREBBP 2item
  23. EP300 2item
  24. PARP 1 item
  25. phosphatases 1 item
  26. G9a 1 item
  27. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  28. Cytidine deaminases 1 item
  29. PP4 1 item
  30. c-RET 1 item
  31. Histone Acetyltransferases (HATs) 1 item
  32. Lck 1 item
  33. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 47item
  2. Cell Experiments 36item
Related Disease
  1. Acute Myeloid Leukemia 7item
  2. Bladder Cancer 2item
  3. Bladder Carcinoma 1 item
  4. Breast Cancer 13item
  5. Cancer 38item
  6. Cervical Cancer 1 item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 7item
  9. Colorectal Cancer 4item
  10. Diabetes 1 item
  11. Glioblastoma 2item
  12. Glioma 2item
  13. Hepatic Cancer 1 item
  14. Hepatocellular Carcinoma 1 item
  15. HIV Infections 1 item
  16. Leukemia 3item
  17. Lung Cancer 4item
  18. Lymphoma 2item
  19. Melanoma 1 item
  20. Mixed Lineage Leukemia 1 item
  21. Multiple Myeloma 3item
  22. Myelofibrosis 1 item
  23. Myeloma 1 item
  24. Neuroblastoma 1 item
  25. Neuronal Protection 1 item
  26. Non-small Cell Lung Cancer 2item
  27. Ovarian Cancer 5item
  28. Pancreatic Cancer 2item
  29. Prostate Cancer 10item
  30. Psoriasis 1 item
  31. Renal Cancer 1 item
  32. Renal Cell Carcinoma 2item
  33. Rheumatoid Arthritis 2item
  34. Thyroid Cancer 1 item
  35. Type 2 Diabetes 2item